Neprilozone (Nepricor)
Product detail for Neprilozone, INN: neprilozone. Therapeutic area: Cardiovascular. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-004
INN
neprilozone
Therapeutic Area
Cardiovascular
Status
Pending
Owner
Carlos Mendez
Created
2023-02-03
Last Updated
2024-04-25
Markets
8
Presentations
| Form | Strength | Route |
|---|---|---|
| Soft capsule | 1 mg/mL | Subcutaneous |
| Solution for injection | 10 mg/mL | Subcutaneous |
| Transdermal patch | 0.5 mg | Oral |
| Soft capsule | 40 mg/0.4 mL | Intravenous |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-007 | Neuravastatin | neuravastatin | 81356-97-8 | biologic | Pending |
| SUB-050 | Magnesium stearate | magnesium stearate | 34996-97-9 | combination | Pending |
Applications (4)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| NMPA-2021-0004 | China | MAA | Approved | Nadia Petrova | 2023-07-05 |
| COFEPRIS-2021-0034 | China | Lifecycle Extension | Blocked | James O'Brien | 2022-11-10 |
| NMPA-2021-0064 | China | sMAA | Pending | Marcus Webb | 2022-08-29 |
| COFEPRIS-2021-0094 | China | Type IB Variation | Blocked | Marcus Webb | 2024-01-24 |
Markets (8)